.png)
Are You Selling What the Sponsor Needs, or Everything You Can Do?
In the CDMO world, we talk a lot about capabilities.
More technologies. More platforms. More sites. More services. More ways to support a molecule from one development stage to the next.
On paper, breadth is impressive.
But from a sponsor’s perspective, more is not automatically better.
In fact, presenting too many capabilities without helping the sponsor understand which ones actually matter can make the decision harder, not easier.
That is where strong business development becomes important.
Our job is not to show a sponsor everything our organization can do.
Our job is to understand what they are trying to accomplish well enough to help them determine what they actually need.
There is a big difference.
Capability Is Only Valuable When It Solves the Right Problem
A sponsor does not need every service your organization offers.
They need the right services for their program.
That sounds obvious, but capability conversations can quickly become centered on the CDMO rather than the sponsor.
We have this technology.
We can do this in-house.
We also offer this service.
We can support the next phase too.
All of those things may be true, but the more important question is:
Does any of it solve the problem the sponsor is trying to solve right now?
A capability becomes valuable when it addresses a specific need, reduces a meaningful risk, creates efficiency, or helps the sponsor reach an important milestone.
Without that connection, it is simply another item on a capabilities slide.
Why it matters: Sponsors are not buying capabilities. They are buying a path forward for their program.
More Options Can Make the Decision Harder
There is a natural assumption that giving a sponsor more options creates more value.
Sometimes it does.
Sometimes it creates more work.
If every possible service, technical pathway, and development option is presented with equal weight, the sponsor is left to determine what matters.
That is particularly difficult for smaller biotech companies that may not have large internal CMC, manufacturing, regulatory, or procurement teams.
They did not engage a CDMO because they wanted another list of decisions to make.
They often need expertise to help them make those decisions.
Strong BD professionals recognize when a sponsor needs options and when they need a recommendation.
There is a meaningful difference between saying:
“Here are the five things we could do.”
And:
“Based on what you have told us about your program, here is the approach I think makes the most sense, and here is why.”
Why it matters: Expertise is not demonstrated by showing everything you know. It is demonstrated by knowing what is relevant.
Start With the Sponsor’s Priorities, Not Your Capabilities
Before deciding what to present, understand what the sponsor is optimizing for.
Speed?
Budget?
Risk reduction?
Internal resource limitations?
A regulatory milestone?
Flexibility as the program evolves?
Those priorities should determine which capabilities enter the conversation.
If timeline is the primary driver, the discussion should focus on the capabilities and strategy that protect the timeline.
If budget is constrained, the conversation may need to focus on what is essential now versus what can reasonably happen later.
If the sponsor has a very small internal team, integrated support may be incredibly valuable.
The same capability can be highly valuable to one sponsor and almost irrelevant to another.
Why it works: When you begin with priorities, your capabilities become answers instead of talking points.
Sometimes the Best Recommendation Is Less
This can be uncomfortable in business development.
If your organization can provide five services, there can be a temptation to position all five.
But sometimes the sponsor only needs three.
Maybe an activity can wait until a later development stage.
Maybe the sponsor already has a strong partner for part of the work.
Maybe bundling everything together creates unnecessary cost or complexity.
Recommending less in those situations does not make you less effective at BD.
It can make you considerably more credible.
You are demonstrating that your recommendation is based on what makes sense for the program, not simply on maximizing the initial scope.
And that distinction matters.
A smaller scope that performs well can become the foundation of a much larger relationship.
Why it matters: Long-term partnerships are rarely built by extracting the maximum value from the first transaction. They are built by creating value repeatedly.
Breadth Still Matters, But Only When It Has Purpose
None of this means broad capabilities are unimportant.
They can be a significant advantage.
A CDMO that can support multiple stages of development may reduce technology transfers, simplify vendor management, preserve program knowledge, and provide continuity as a molecule progresses.
Those are meaningful benefits.
But the value is not simply that all of those capabilities exist.
The value is what those capabilities allow the sponsor to accomplish.
That is the story BD should be telling.
Instead of:
“We can take you from development through commercialization.”
Ask:
“If this program progresses as planned, what would continuity across those stages mean for your team?”
Now you are discussing the impact rather than the inventory.
Your Capability Deck Shouldn’t Lead the Conversation
Capability decks have a purpose.
But they should support the conversation, not become the conversation.
If you spend 30 minutes walking through everything your organization can do before truly understanding the sponsor’s program, you are asking the sponsor to do the work of figuring out what is relevant.
BD should be doing that work.
Listen first.
Understand the program.
Identify the priorities.
Then bring forward the capabilities that matter and explain why they matter.
Everything else can wait until it becomes relevant.
The Bigger Picture
More capabilities can absolutely make a CDMO more competitive.
But only if the sponsor can clearly see how those capabilities create value for their program.
The strongest BD professionals do not overwhelm sponsors with everything their organization can offer.
They curate.
They connect capabilities to priorities.
They simplify decisions.
And when appropriate, they are willing to recommend less.
Because the goal is not for the sponsor to leave the conversation thinking:
“Wow, they can do a lot.”
The goal is for them to leave thinking:
“They understand exactly what we need.”
If you want to strengthen how you uncover sponsor priorities, position the right capabilities, and guide conversations around what actually creates value, my course Ask Smarter, Close Sooner was built for business development professionals in CDMOs. It provides practical frameworks for asking better questions, understanding what sponsors actually need, and positioning solutions in a way that builds trust and moves opportunities forward.
For more insights and personalized support in navigating the biotech-CDMO landscape, visit my website: www.yourpharmagirl.com and follow Your Pharma Girl on LinkedIn.
Whether you need strategic guidance, tailored BD solutions, or expert advice on building lasting partnerships, I am here to help you and your team succeed at every stage of development.
Comments